HTAi 2011


	Bienvenidos
	Tema
	Organizadores
	Comités
	Auspicio y Exposición
	Programa Cientifico
	- Plenarias[NUEVO]
	- Premios
	- Sesiones Orales[NUEVO]
	- Paneles[NUEVO]
	Inscripciones
	Actividades Pre-Conferencia
	Trabajos Científicos
	Local
	Alojamiento y Paseos
	Programa Social
	Becas de Viaje
	Información de Viaje
	Compensación de Carbono
	Acerca Rio de Janeiro
	Links de interés
	Contacto
	Login de congresistas

NOTICIAS

Estimado participante,
Su opini�n es muy importante para nosotros. Por favor, conteste el cuestionario on-line acerca de su experiencia en la 8� Conferencia Anual HTAi.
Acceso: http://www.surveymonkey.com
Equipo Organizador del HTAi 2011

SESIONES ORALES

PRESENTACIONES EN PDF

� OS16 - Medicines Policy and Sustainability;
236 - Exceptional Higher Allowed Price of Medicines in Slovenia. Does HTA Fit In? Eva Turk	E.T. PDF version
379 - Multiple Demand Side Measures Needed to Enhance Prescribing of Generics for Sustainable Healthcare: Experiences From Abu Dhabi Brian Godman	B.G. PDF version
448 - Policy Framework for Tiered Pricing to Improve Access and Affordability of Medicines In Low and Middle Income Countries Rutger Daems	R.D. PDF version
660 - Management Model to Replace an Original High Cost Drug for a Generic Formulation. Evaluation, Monitoring and Results Abayub� Perna	A.P.F. PDF version
816 - The Effect of HTA on Reimbursed Pharmaceutical Prices � Preliminary Results from an International Empirical Analysis Peter Davey	P.D. PDF version

� OS17 - Applying of Health Technology Assessment;
594 - Evidence Based Essential Medicines and Herbal Medicines Selection: Training of Brazilian Expert Commissions Marcus Tolentino Silva	M.T.S. PDF version
706 � The Role of DECIT on Decision Making About Incorporation Of Health Technologies In Brazilian Health System In 2010 Fl�via Cristina Ribeiro Salomon	F.C.R.S. PDF version

� OS18 - HTA Report Utilization;
304 - Evaluation of Implementation Process of Prenatal Screening in Finland Ulla Saalasti-Koskinen	U.S.K. PDF version
460 - Telemedicine Support on Maternal and Newborn Health in Remote Provinces of Mongolia Oyun Chimeddamba	O.C. PDF version
518 - Review of Decision-Analytic Models in Chronic Myeloid Leukemia Ursula Rochau	U.R. PDF version
736 - Review of Studies on Economic Evaluation of Treatment for Osteoporosis Postmenopausal Cristina Mariano Ruas Brand�o	C.M.R.B. PDF version

� OS19 - National Health Policies And HTA Agencies;
214 - North-South and South-South HTA Transferability: The Experiences of Latin American Researchers and Decision-Makers in Using HTA Reports from Other Jurisdictions Andres Pichon-Riviere	A.P. PDF version
393 - Innovative Health Technologies: Criteria and Incentives in France Sun-Hae Lee-Robin	S.H.L.R. PDF version
462 - Accountability for Reasonableness of Drug Reimbursement Systems: Comparison of the Austrian, Belgian, Dutch, French and Swedish System and Development of a Transparency Framework for Decision Making Irina Cleemput	I.C. PDF version
899 - HTA: The Anchor in a Sea Of Political Change Peter Littlejohns	P.L. PDF version
945 - Institutionalizing HTA in Brazil: A Comparative Analysis With the UK, Canada and Australia Vania Cristina Canuto Santos	V.C.C.S. PDF version

� OS20 - HTA and Patient Perspective;
374 - Strategies to Enroll Patients to an Integrated Program for Breast Cancer Care � A Partnership Between Health Services, Schools and a Non-Governmental Organization Camila Cristina Pires Nascimento	C.C.P.N. PDF version
430 - Introducing Patients� Perspective in Health Technology Assessment at the Local Level: A Qualitative Study Among HTA Producers and Hospital Managers Marie-Pierre Gagnon	M.P.G. PDF version
956 - Ethics and Policy in HTA: Patient Preferences at Odds With HTA- The Example of Autologous Blood Donation for Spinal Fusion David A Wong	D.A.W PDF version

1-2-3-4-5-6